"Our drug portfolio generates billions in revenue. Why should we invest in digital innovation when it will never come close to what we make from our drugs?"

We get it.

Building a case for digital innovation is hard.
Let us help you find a way.

We work with some of the most sophisticated executives. We love delighting them

Digital Therapeutics

Assessed the scientific validity and commercial opportunity of 85 digital therapeutics, leading to an entry-path recommendation for the client

Digital Biomarkers

Uncovered 45 predictive digital biomarkers across three therapeutic areas, resulting in 3 co-development pilots

Digital Ecosystem Access

Provided rapid access to innovation ecosystems in Israel, Singapore, Toronto and Silicon Valley and mapped 120 relevant digital technologies

Horizon Scan and Pilots

Identified five 'around the corner' emerging digital opportunity spaces and set up 8 pilots for rapid testing, learning and co-development

Digital Innovation Lab

Launched a Digital Health Innovation Lab in Toronto, Tel Aviv, Boston, Silicon Valley and China resutling in 25 digital projects, investments and spinouts

Medication Adherence Tools

Scouted and piloted adherence technology for both clinical trials and real-world use cases, resulting in 5 partnerships and co-development deals

Digitizing the Value Chain

Diagnosed the full pharma value chain and recommended 5 opportunity areas for near-term digitization and revenue generation potential

Digital Launch

Created a Go-to-Market strategy for a Pharma company that recently-acquired a software business and needed to drive revenues quickly

Stealth Mode Scouting

Uncovered 49 stealth-mode companies that were not on any databases and created informational arbitrage for future partnerships and investments

Cross-Industry Deep Tech

Utilized non-pharma technologies like voicetech and eye-tracking to uncover new biomarkers and therapeutics for novel pharma use cases